Testing new antifungal treatments in the lab
Official title: Task A29: In vitro screening for antifungal activity against fungal disease pathogens
Funded at University of Texas Hlth Science Center · NIH-11303067 · Data updated 2026-11-12
This study is looking at new antifungal medicines in the lab to find better ways to treat fungal infections and the harmful substances they create.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project start | December 11, 2024 |
| Project end | December 10, 2025 |
| Funding year | 2025 |
| Award (this year) | $78,390 |
| NIH project number | 75N93019D00022-0-759302500001-1 |
| Project ID | NIH-11303067 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with fungal infections or those at high risk of developing such infections.
✕Less likely to help
Patients with non-fungal related infections or conditions will likely not benefit from this research.
What this research studies
This research focuses on evaluating the effectiveness of new antifungal agents through laboratory testing. It involves in vitro screening, which means that the tests are conducted in controlled environments outside of living organisms. The goal is to identify potential treatments that can combat fungal diseases and the toxins they produce. By maintaining fungal and toxin stocks, researchers can develop and refine assays to better assess the efficacy of these agents.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective antifungal treatments for patients suffering from fungal infections.
How similar studies have gone: Previous research has shown promise in developing antifungal agents through similar in vitro testing approaches.
Where this research is happening
-
University of Texas Hlth Science Center
San Antonio, United States Active
Researchers
- Principal investigator: Patterson, Thomas — University of Texas Hlth Science Center
- Study coordinator: Patterson, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.